Showing results (1251-1260 of 2,043) with videos related to

Sort By:
Pageof 205
American Journal of Obstetrics and Gynecology|March 18, 2014
Association between maternal characteristics, abnormal serum aneuploidy analytes, and placental abruptionYair J Blumenfeld, Rebecca J Baer, Maurice L Druzin, et al.
Research Square|November 1, 2024
Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson's disease miceMatteo Santoro, Rachel K Lam, Sarah E Blumenfeld, et al.
Epilepsia|November 19, 2024
Automatic responsiveness testing in epilepsy with wearable technology: The ARTiE WatchLydia Wheeler, Vaclav Kremen, Cole Mersereau, et al.
Journal of Clinical Medicine|March 17, 2025
The Role of Baseline Total Kidney Volume Growth Rate in Predicting Tolvaptan Efficacy for ADPKD Patients: A Feasibility StudyHreedi Dev, Zhongxiu Hu, Jon D Blumenfeld, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|June 30, 2022
Seizure semiology: ILAE glossary of terms and their significanceSándor Beniczky, William O Tatum, Hal Blumenfeld, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 29, 2026
Recombinant Human Amelogenin Protein Enhances Tendon-To-Bone Healing in a Rat Rotator Cuff Tear ModelShany Ivon Markowitz, Shlomi Bulkowstein, Michael Emanuel, et al.
Medicina|October 2, 2003
[Neumonía acquired in the community. Practical guide elaborated by a committee intersocieties]Carlos M Luna, Aníbal Calmaggi, Oscar Caberloto, et al.
Neuroimage|April 29, 2009
DTI abnormalities in anterior corpus callosum of rats with spike-wave epilepsyH Chahboune, A M Mishra, M N DeSalvo, et al.
NPJ Parkinson'S Disease|February 11, 2025
Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson's disease miceMatteo Santoro, Rachel K Lam, Sarah E Blumenfeld, et al.
Pageof 205